: Central Venous Catheters and Associated Products

The Framework Agreement will be for supply of Central Venous Catheters and Associated Products to NHS Supply Chain and to the NHS Supply Chain customer base via the E-Direct Route. The Framework term will be on a 2+ 2 year basis (with a maximum term of 48 months). It is anticipated that initial expenditure will be in the region of £30,000,000 to £34,125,000 in the first year of this Framework Agreement, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement. Estimated value over the maximum 4 year Framework Agreement (2 + 2 Term) will be in the region of £120,000,000 to £136,500,000.

The Framework Agreement between NHS Supply Chain and successful suppliers will reserve the right to purchase the same or similar supplies and/or services from suppliers not appointed to the Framework Agreement at its sole discretion.

NHS Supply Chain intends to enter into arrangements under which it will be entitled to purchase supplies and/or services which it will make available for purchase by 1) any NHS Trust; 2) any other NHS entity; 3) any government department, agency or other statutory body and/or 4) any private sector entity active in the UK healthcare sector. Only NHS Supply Chain can order from the Framework Agreement and enter into contracts under it.

NHS Supply Chain seeks to establish a Framework Agreement for supply to NHS Supply Chain depots via the Stock route and to the NHS Supply Chain customer base via the E-Direct Route for the supply of Acute Central Venous Catheter products. This framework covers products that are used to administer medicines, fluids both short-term and long-term intravenously. Additional information: Precise quantities are unknown. It is anticipated that initial expenditure will be in the region of £4,098,932 to £4,844,192 in the first year of this Framework Agreement, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement.

NHS Supply Chain seeks to establish a Framework Agreement for supply to NHS Supply Chain depots via the Stock route and to the NHS Supply Chain customer base via the E-Direct Route for the supply of Vascular Central Venous Catheter products. This framework covers products that are used to administer medicines, fluids both short-term and long-term intravenously. Additional information: Precise quantities are unknown. It is anticipated that initial expenditure will be in the region of £582,806 to £688,770 in the first year of this Framework Agreement, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement.

NHS Supply Chain seeks to establish a Framework Agreement for supply to NHS Supply Chain depots via the Stock route and to the NHS Supply Chain customer base via the E-Direct Route for the supply of Peripheral Inserted Central Catheter. This framework covers products that are used to administer medicines, fluids both short-term and long-term intravenously. Additional information: Precise quantities are unknown. It is anticipated that initial expenditure will be in the region of £11,868,194 to £14,026,047 in the first year of this Framework Agreement, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement.

NHS Supply Chain seeks to establish a Framework Agreement for supply to NHS Supply Chain depots via the Stock route and to the NHS Supply Chain customer base via the E-Direct Route for the supply of Skin Tunnelled (Cuffed) Catheter products. This framework covers products that are used to administer medicines, fluids both short-term and long-term intravenously. Additional information: Precise quantities are unknown. It is anticipated that initial expenditure will be in the region of £731,343 to £864,314 in the first year of this Framework Agreement, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement.

NHS Supply Chain seeks to establish a Framework Agreement for supply to NHS Supply Chain depots via the Stock route and to the NHS Supply Chain customer base via the E-Direct Route for the supply of Implanted Port products. This framework covers products that are used to administer medicines, fluids both short-term and long-term intravenously. Additional information: Precise quantities are unknown. It is anticipated that initial expenditure will be in the region of £709,843 to £838,905 in the first year of this Framework Agreement, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement.

NHS Supply Chain seeks to establish a Framework Agreement for supply to NHS Supply Chain depots via the Stock route and to the NHS Supply Chain customer base via the E-Direct Route for the supply of Arterial Line products. This framework covers products that are used to administer medicines, fluids both short-term and long-term intravenously. Additional information: Precise quantities are unknown. It is anticipated that initial expenditure will be in the region of £3,315,879 to £3,918,766 in the first year of this Framework Agreement, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement.

NHS Supply Chain seeks to establish a Framework Agreement for supply to NHS Supply Chain depots via the Stock route and to the NHS Supply Chain customer base via the E-Direct Route for the supply of Midline products. This framework covers products that are used to administer medicines, fluids both short-term and long-term intravenously. Additional information: Precise quantities are unknown. It is anticipated that initial expenditure will be in the region of £1,609,077 to £1,901,637 in the first year of this Framework Agreement, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement.

NHS Supply Chain seeks to establish a Framework Agreement for supply to NHS Supply Chain depots via the Stock route and to the NHS Supply Chain customer base via the E-Direct Route for the supply of Catheter Accessories and Associated products. This framework covers products that are used to administer medicines, fluids both short-term and long-term intravenously. Additional information: Precise quantities are unknown. It is anticipated that initial expenditure will be in the region of £5,876,313 to £6,944,734 in the first year of this Framework Agreement, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement.